Agenda
8:30 AM — 9:30 AM
9:30 AM — 10:00 AM
Welcome & Opening Remarks10:00 AM — 12:00 PM
Session 1 - Scientific Advances: The Concept of Biosimilarity12:00 PM — 1:00 PM
1:00 PM — 2:30 PM
Session 2 - Policy Considerations2:30 PM — 3:00 PM
3:00 PM — 5:00 PM
Session 3 - Naming, Labeling and Postmarketing Activities5:30 PM — 6:30 PM
7:30 AM — 8:30 AM
8:30 AM — 10:00 AM
Session 4 - Global Regulatory Landscape10:00 AM — 10:30 AM
10:30 AM — 12:30 PM
Session 5 - Clinical Perspectives12:30 PM — 1:30 PM
1:30 PM — 3:30 PM
Session 6 - Commercialization3:30 PM — 4:00 PM
4:00 PM — 5:00 PM
Session 7 - Regulatory UpdateHave an account?